ACE2 is also expressed on the surface of epithelial cells in lungs, heart, kidneys, and intestine, facilitating viral entry to these tissues and hence might underlie the multi-organ dysfunction seen with COVID-19 (Zhang et al., 2020). This evidence concerns the gene ACE2 and COVID-19.